Approved Study Database

Ref. No. Scientific Title Principal investigator
2011.510 Comparison of the effect of denosumab and alendronate on bone density and microarchitecture in rheumatoid arthritis females with low bone mass: A randomized controlled trial Prof. Tam Lai Shan
2011.483 Effect of treat-to-target strategies aiming at remission compared with minimal disease activity on arterial stiffness in early rheumatoid arthritis - a randomized controlled study Prof. TAM Lai Shan
2014.082 A Dose-Blinded, 2-Dose Level, Parallel-Group, Multicenter, Long Term Extension Study to Evaluate the Long-Term Safety, Efficacy, and Immunogenicity of BIIB023 in Subjects with Lupus Nephritis Prof. TAM Lai Shan
2008.344 Premature Atherosclerosis in Early Rheumatoid Arthritis Prof Tam Lai Shan
2009.429 A Phase 2A, Randomized, Double-Blind, Active and Placebo-Controlled Study of PF-04171327 in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis Dr. TAM Lai Shan
2010.491 Effect of early intensive treatment in patients with recent-onset rheumatoid arthritis Prof. TAM Lai Shan
2012.559 A randomized, double-blind, parallel, placebo-controlled study assessing the efficacy and safety of sarilumab added to non-biologic DMARD therapy in patients with rheumatoid arthritis who are inadequate responders to or intolerant of TNF-α antagonists Prof. TAM Lai Shan
2012.557 A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab Prof. TAM Lai Shan
2008.343 The Chinese University of Hong Kong Early Arthritis Study Prof Tam Lai Shan
2012.558 An adaptive Phase II study to evaluate the efficacy, pharmacodynamics, safety and tolerability of GSK2586184 in patients with mild to moderate systemic lupus erythematosus Professor Tam Lai Shan
2020.617 Subclinical atherosclerosis in axial spondyloarthritis- a cross-sectional study Prof. TAM Lai Shan
譚麗珊
2023.317 Early identification of axial psoriatic arthritis among patients with psoriasis: a screening study using low-dose computed tomography Prof. TAM Lai Shan
2021.706 Effect of Achieving Minimal Disease on the Progression of Subclinical Coronary Atherosclerosis: A Citywide Prospective Cohort Study in Psoriatic Arthritis Prof. TAM Lai Shan
譚麗珊
2020.530 5-Year Cardiovascular Event Risk in Early Rheumatoid Arthritis Patients who received Treat-to-Target Management: a population-based cohort study Prof. TAM Lai Shan
譚麗珊
2021.568 A Phase 4, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Bio-naive Participants with Active Psoriatic Arthritis Axial Disease Prof. TAM Lai Shan
譚麗珊
2020.519 Cardiovascular events in axial spondyloarthritis Prof. TAM Lai Shan
譚麗珊
2022.151 Osteosarcopenia Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) and fracture risk in non-osteoporotic patients with immune-mediated inflammatory disease Prof. TAM Lai Shan
譚麗珊
2023.189 Survey of cardiovascular disease Risk Factors in Psoriatic Arthritis Prof. TAM Lai Shan
2023.051 Discovering new post-translational modification patterns for the early diagnosis of rheumatoid arthritis Prof. TAM Lai Shan
2023.306 Low-dose computed tomography for the detection of structural changes in axial psoriatic arthritis Prof. TAM Lai Shan
2021.401 A Multicentre, Randomised, Double-blind, Placebo-controlled, Phase III Study Evaluating the Efficacy and Safety of Anifrolumab in Asian Participants with Active Systemic Lupus Erythematosus Prof. TAM Lai Shan
譚麗珊
2023.181 Anti-inflammatory mechanisms of immune-adipose-related Meteorin-like protein (METRNL) in Systemic Lupus Erythematosus Dr. TAM Lai Shan
2022.686 Bone Erosion Volume Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of disability in patients with psoriatic arthritis Prof. TAM Lai Shan
2021.343 AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS COHORT (AXIS) a joint ASAS-GRAPPA project Prof. TAM Lai Shan
譚麗珊
2021.187 A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Dapirolizumab pegol in Study Participants with Moderately to Severely Active Systemic Lupus Erythematosus Prof. TAM Lai Shan
譚麗珊 教授
2020.704 Bone Erosion Volume Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of disability in patients with rheumatoid arthritis Prof. TAM Lai Shan
2021.460 Profiling of Serum Protein Biomarkers in Psoriatic Arthritis–Associated Disease Activity Assessment and Bone Damage Prof. TAM Lai Shan
譚麗珊
2023.355 Sex- And Gender-based analysis of the Effectiveness of advanced therapies in Psoriatic Arthritis Prof. TAM Lai Shan
2020.516 CUHK Rheumatology Research Centre Imaging Database of Rheumatic Diseases Prof. TAM Lai Shan
譚麗珊
2023.127 Machine learning models to quantify and predict radiographic joint damage in rheumatoid arthritis Prof. TAM Lai Shan
Lai Shan TAM
2021.315 Axial involvement in patients with Psoriatic Arthritis in Hong Kong – a cross-sectional pilot study Prof. TAM Lai Shan
譚麗珊
2017.700 Circulating microRNA 99b as biomarker for predicting the early development, repair and progression of bone erosions in early rheumatoid arthritis using HR-pQCT Prof. TAM Lai Shan
譚麗珊
2018.144 Bone Microarchitecture Assessed by 3D High-resolution Peripheral Quantitative Computed Tomography (HR-pQCT) as predictor of fracture risk in patients with glucocorticoid-induced osteoporosis Prof. TAM Lai Shan
譚麗珊
2019.264 Incidence of and associated factors of infective complications in rheumatology patients taking DMARDs Dr. TAM Lai Shan
2020.129 Vascular effects of achieving low disease activity in axial spondyloarthritis - a 2-year prospective cohort study Prof. TAM Lai Shan
譚麗珊
2017.605 Evaluation of molecular and cellular dysregulation in systemic lupus erythematosus Prof. TAM Lai Shan
2017.683 Calprotectin in psoriatic arthritis Prof. TAM Lai Shan
譚麗珊
2017.633 An exploratory maintenance trial evaluating the effect of BI 655064 in Lupus Nephritis patients who have achieved a meaningful response either at the end of 1293.10 or after an induction treatment outside of 1293.10 Prof. TAM Lai Shan
譚麗珊教授
2019.540 A PHASE 2B, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06700841 IN PARTICIPANTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS (SLE). Dr. TAM Lai Shan
譚麗珊
2020.128 Portable integrated diagnostic platform for chronic auto-immune diseases Prof. TAM Lai Shan
譚麗珊
2019.224 Effects of achieving SDAI remission on joint space outcomes progression in early rheumatoid arthritis: an HR-pQCT study Prof. TAM Lai Shan
譚麗珊
2019.180 The microbiome study in psoriasis and psoriatic arthropathy patients in Hong Kong Prof. TAM Lai Shan
譚麗珊
2019.247 Survival benefit of statin use in patients with immune mediated inflammatory diseases in Hong Kong - A population-based study Prof. TAM Lai Shan
2020.141 Quantification of erosion, joint space width and new bone formation using deep learning-based approaches Prof. TAM Lai Shan
譚麗珊
2018.417 Prevention of metacarpophalangeal joints structure damage in patients with psoriatic arthritis using tofacitinib Prof. TAM Lai Shan
2019.063 Effects of tight-control strategy with rosuvastatin on progression of subclinical carotid and coronary atherosclerosis in psoriatic arthritis- a prospective cohort study Prof. TAM Lai Shan
譚麗珊
2018.225 The APLAR Spondyloarthritis (SpA) Registry Prof. TAM Lai Shan
譚麗珊
2019.573 Subclinical gut inflammation and gut microbiome in axial spondyloarthritis patients in Hong Kong Prof. TAM Lai Shan
譚麗珊
2019.401 Immunological role of the ILC2-B lymphocyte regulatory axis in systemic lupus erythematosus Prof. TAM Lai Shan
譚麗珊
2019.650 Effects of tight-control strategy with and without rosuvastatin on progression of subclinical coronary and carotid atherosclerosis in psoriatic arthritis- a randomized placebo-controlled study Prof. TAM Lai Shan
譚麗珊

Page 71 of 288.